Tag Archives: gemcitabine

Which is Best Chemotherapy Option for Advanced Bladder Cancer?

Posted on May 15, 2011 by wngai

Transitional cell or urothelial carcinoma is the most common type of bladder cancer, accounting for more than 90% all bladder cancers. This type of cancer is sensitive to treatment with chemotherapeutic agents. This type of cancer is usually treated with … Continue reading →

Posted in Bladder Cancer, Cancer | Tagged advanced bladder cancer, carboplatin, chemotherapy, Cisplatin, doxorubicin, gemcitabine, methotreaxate, MVAC, Transitional cell carcinoma, urothelial carcinoma, vinblastine | Comments Off

First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population

Posted on October 16, 2010 by wngai

First-line erlotinib (Tarceva) tripled the progression-free survival in advanced non–small cell lung carcinoma (NSCLC) patients who had endothelial growth factor receptor (EGFR)-activating mutation, according to the OPTIMAL study presented at the 35th European Society for Medical Oncology Congress. The study … Continue reading →

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged carboplatin, endothelial growth factor receptor, erlotinib, gemcitabine, Gemzar, non–small cell lung carcinoma, NSCLC, OPTIMAL, progression-free, Survival, Tarceva | Comments Off

New Hope for Heavily Pretreated Metastatic Breast Cancer Patients

Posted on June 26, 2010 by wngai

A new chemotherapy agent, eribulin (developed by Eisai), was shown to improve significant survival benefit in heavily pretreated breast cancer, according to the EMBRACE study presented at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting. The new drug … Continue reading →

Posted in Breast cancer, Cancer | Tagged anthracyclines, capecitabine, EMBRACE, eribulin, gemcitabine, halichondrins, Metastatic breast cancer, Survival, taxane, vinorelbine | Comments Off

Pancreatic cancer – Causes, Prevention, Prognosis, Diagnosis and Latest Treatment

Posted on April 17, 2010 by wngai

Prevalence Pancreatic cancer is the fourth most common cause of adult cancer death, accounting for an estimated 42,470 new cases and 35,240 deaths in USA for 2009. The high mortality rate is due to the high incidence of metastatic disease … Continue reading →

Posted in Pancreatic Cancer | Tagged Avastin, bevacizumab, capecitabine, Causes, Diagnosis, Eloxatin, erlotinib, gemcitabine, Gemzar, oxaliplatin, Pancreatic Cancer, Prevention, Prognosis, Survival, Tarceva, Treatment, Xeloda | 2 Comments

New Standard Treatment for Advanced Biliary Tract Cancer: Cisplatin Plus Gemcitabine

Posted on April 11, 2010 by wngai

Good news for patients with advanced biliary tract cancer. Combination of cisplatin and gemcitabine (Gemzar) have been shown to be an effective treatment option for patients with locally advanced or metastatic biliary tract cancer. In developed nations, biliary tract cancer … Continue reading →

Posted in Cancer, Gallbladder cancer | Tagged Biliary tract cancer, cholangiocarcinoma, Cisplatin, gallbladder cancer, gemcitabine, Gemzar, Survival | Comments Off

Alternative Treatment Options for Late Stage Lung Cancer Patients

Posted on March 7, 2010 by wngai

Paclitaxel plus carboplatin(PC) is the current standard regimen for advanced or metastatic non-small-cell lung cancer (NSCLC) patients. However, paclitaxel is associated with serious toxicity such as peripheral neuropathy. A tria,l published in October version of the Annals of Oncology, was … Continue reading →

Posted in Cancer, Lung Cancer | Tagged carboplatin, chemotherapy, gemcitabine, Lung Cancer, NSCLC, paclitaxel, Stage III, Stage IV, Survival | Comments Off